Japan, Jan. 20 -- ABL BIO INC has got intellectual property rights for 'BISPECIFIC ANTIBODY TO A-SYN/IGF1R AND USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-103513
Category (FI): C07K16/28,C07K16/18,C07K16/46,C12N15/13,A61K39/395@N,C12N15/62@Z,A61P25/16,A61P25/28
Stage: Grant (IP right granted following substantive examination.)
Filing Date: June 27, 2024
Publication Date: Nov. 6, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....